Citation

Callaway JC, Grob CS. J. Psychoactive Drugs 1998; 30(4): 367-369.

Affiliation

Department of Pharmaceutical Chemistry, University of Kuopio, Finland.

Copyright

(Copyright © 1998, Haight-Ashbury Publications in association with the Haight-Ashbury Free Medical Clinic)

DOI

unavailable

PMID

9924842

Abstract

The Amazonian psychoactive plant beverage ayahuasca has attracted increasing interest in recent years. Little attention has been given, however, to potentially dangerous interactions with other drugs. In particular, the interaction between the potent monoamine oxidase-inhibiting harmala alkaloids in ayahuasca and the selective serotonin reuptake inhibitor (SSRI) class of antidepressants may induce a serotonin syndrome with potentially grave outcome. Caution is advised when combining ayahuasca with certain pharmaceutical drugs.

Language: en